ARCHIVES

HEW Secretary Tells Ethics Board To Take Up Issue of Compensation

This article is from The Cancer Letter archive.

Vol. 05 No. 39 | September 28, 1979

Download PDF Visit The Full Archive

Related Articles

FDA approves Irinotecan, Days After ODAC Meeting

June 21, 1996

Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up

December 26, 2014

Sequestration Hurts Kids with Cancer

March 15, 2013

FDA Proposes Office For Patients With Life Threatening Disease

November 13, 1992

NTP Panel Agrees PBB Carcinogenic, Two Asbestos Varieties Are Not

July 3, 1981

In Brief: BCDDP “Dramatically” Changed U.S. Medical Practice, Fink Says; *% Not too uch-DeVita

December 15, 1978